I. Dogan Et Al. , "Trastuzumab-based treatment of HER2-positive metastatic gastric cancer," ESMO 22nd World Congress on Gastrointestinal Cancer , vol.31, ELECTR NETWORK, 2020
Dogan, I. Et Al. 2020. Trastuzumab-based treatment of HER2-positive metastatic gastric cancer. ESMO 22nd World Congress on Gastrointestinal Cancer , (ELECTR NETWORK).
Dogan, I., Karabulut, S., Tastekin, D., Paksoy, N., Sakar, B., & Vatansever, S., (2020). Trastuzumab-based treatment of HER2-positive metastatic gastric cancer . ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK
Dogan, I. Et Al. "Trastuzumab-based treatment of HER2-positive metastatic gastric cancer," ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 2020
Dogan, I. Et Al. "Trastuzumab-based treatment of HER2-positive metastatic gastric cancer." ESMO 22nd World Congress on Gastrointestinal Cancer , ELECTR NETWORK, 2020
Dogan, I. Et Al. (2020) . "Trastuzumab-based treatment of HER2-positive metastatic gastric cancer." ESMO 22nd World Congress on Gastrointestinal Cancer , ELECTR NETWORK.
@conferencepaper{conferencepaper, author={I. Dogan Et Al. }, title={Trastuzumab-based treatment of HER2-positive metastatic gastric cancer}, congress name={ESMO 22nd World Congress on Gastrointestinal Cancer}, city={}, country={ELECTR NETWORK}, year={2020}}